Title : Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment.

Pub. Date : 2011 Aug 1

PMID : 21653686






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment. Docetaxel amphiregulin Homo sapiens
2 CONCLUSIONS: High EGFRvIII and AREG expression levels identify SCCHN patients who are less likely to benefit from combination treatment with cetuximab and docetaxel. Docetaxel amphiregulin Homo sapiens